GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (MEX:CRL) » Definitions » Change In Other Working Capital

Charles River Laboratories International (MEX:CRL) Change In Other Working Capital : MXN-329 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Charles River Laboratories International Change In Other Working Capital?

Charles River Laboratories International's Change In Other Working Capital for the quarter that ended in Mar. 2024 was MXN-115 Mil. It means Charles River Laboratories International's Other Working Capital declined by MXN115 Mil from Dec. 2023 to Mar. 2024 .

Charles River Laboratories International's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was MXN23 Mil. It means Charles River Laboratories International's Other Working Capital increased by MXN23 Mil from Dec. 2022 to Dec. 2023 .

Charles River Laboratories International Change In Other Working Capital Historical Data

The historical data trend for Charles River Laboratories International's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charles River Laboratories International Change In Other Working Capital Chart

Charles River Laboratories International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.53 726.10 113.42 2,365.94 22.66

Charles River Laboratories International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 238.94 -733.42 -173.23 692.62 -114.93

Charles River Laboratories International Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-329 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Charles River Laboratories International's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Charles River Laboratories International (MEX:CRL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (MEX:CRL) » Definitions » Change In Other Working Capital
Comparable Companies
MEDP QGEN EXAS NTRA RVTY DGX LH ILMN RDNT SHC TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT SHSE:603259
Traded in Other Exchanges
CRL:USA RV6:Germany RV6:Germany
Address
251 Ballardvale Street, Wilmington, MA, USA, 01887
Website
https://www.criver.com
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.